In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

During a recent appearance on “The Howard Stern Show," the comedian, 43, opened up about her scary experience trying the medication for weight-loss purposes.

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

Amy Schumer revealed she stopped using the weight-loss drug Ozempic due to severe side effects, including nausea and extreme fatigue. She later discovered a genetic marker made her more susceptible to ...

Amy Schumer has opened up about her experience of using the drug Ozempic to lose weight, revealing she had a 'debilitating' reaction to the once-weekly injection ...

Novo Nordisk stock reversed a three-day downtrend Wednesday after the weight-loss drugs kingpin leaned on Ozempic for a ...

Detailed price information for Compass Inc Cl A (COMP-N) from The Globe and Mail including charting and trades.